SecurityATRS / Antares Pharma, Inc. (036642106)
President & CEOAPPLE ROBERT F
IndustrySurgical and Medical Instruments and Apparatus
Institutional Owners110
Institutional Shares63,028,027 - 40.19%
Common Shares Outstanding156,825,557 shares (as of 2018-03-31)
Institutional Value$ 1,362,323,000 USD

Institutional Stock Ownership and Shareholders()

ATRS / Antares Pharma, Inc. Institutional Ownership

Antares Pharma, Inc. (NASDAQ:ATRS) has 110 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 63,028,027 shares. Largest shareholders include Armistice Capital, Llc, BlackRock Inc., Vanguard Group Inc, Broadfin Capital, LLC, BlackRock Institutional Trust Company, N.A., FMR LLC / Fidelity, State Street Corp, Mycio Wealth Partners, Llc, Wells Fargo & Company/mn, and JW Asset Management, LLC.
Antares Pharma, Inc. (NASDAQ:ATRS) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

Embed this chart! (it updates automatically)
<a href="https://fintel.io/so/us/atrs"><img src="https://images.fintel.io/us-atrs-so.png" alt="ATRS / Antares Pharma, Inc. Institutional Ownership"><a>

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-05-15 13F-HR HighTower Advisors, LLC 13,600 13,600 0.00 26 29 11.54
2018-05-11 13F-HR PNC FINANCIAL SERVICES GROUP, INC. 100,000 100,000 0.00 199 220 10.55
2018-05-15 13F-HR Invesco Ltd. 51,758 56,599 9.35 103 125 21.36
2018-05-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP 138,383 0 -100.00 275 0 -100.00
2018-05-15 13F-HR GEODE CAPITAL MANAGEMENT, LLC 1,283,758 1,298,980 1.19 2,554 2,857 11.86
2018-05-15 13F-HR MANUFACTURERS LIFE INSURANCE COMPANY, THE 118,846 115,943 -2.44 237 256 8.02
2018-05-15 13F-HR CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 228,071 222,098 -2.62 454 489 7.71
2018-05-14 13F-HR TIAA CREF INVESTMENT MANAGEMENT LLC 357,978 340,657 -4.84 712 749 5.20
2018-05-15 13F-HR DEUTSCHE BANK AG\ 319,943 153,007 -52.18 635 336 -47.09
2018-05-15 13F-HR Advisor Group, Inc. 101,837 94,837 -6.87 203 209 2.96
2018-05-14 13F-HR/A CITADEL ADVISORS LLC 13,498 0 -100.00 27 0 -100.00
2018-05-01 13F-HR OPPENHEIMER & CO INC 25,600 25,600 0.00 51 56 9.80
2018-05-14 13F-HR MORGAN STANLEY 793,598 664,736 -16.24 1,578 1,463 -7.29
2018-05-10 13F-HR NEW YORK STATE COMMON RETIREMENT FUND 141,800 141,800 0.00 282 312 10.64
2018-05-15 13F-HR METROPOLITAN LIFE INSURANCE CO/NY 44,868 22,737 -49.32 89 50,021 56,103.37
2017-02-07 13F-HR WILLIAM HARRIS INVESTORS INC 40,000 40,000 0.00 67 93 38.81
2018-05-11 13F-HR Russell Investments Group, Ltd. 890,485 1,959
2018-05-02 13F-HR WELLS FARGO & COMPANY/MN 1,591,407 1,933,469 21.49 3,168 4,253 34.25
2018-05-03 13F-HR Pds Planning, Inc 12,000 12,000 0.00 24 26 8.33
2018-05-15 13F-HR Advisor Group, Inc. Call 250 3
2017-05-16 13F-HR FIRST FINANCIAL EQUITY CORPORATION 29,400 81
2018-05-14 13F-HR RAYMOND JAMES & ASSOCIATES 11,323 0 -100.00 23 0 -100.00
2018-05-23 13F-HR/A Allianz Asset Management AG 776,204 763,011 -1.70 1,545 1,679 8.67
2018-02-15 13F-HR Bb&t Investment Services, Inc. 2,780 2,780 0.00 9 6 -33.33
2018-05-10 13F-HR JP Morgan Chase & Co 70,810 448,634 533.57 141 987 600.00
2018-05-11 13F-HR GSA CAPITAL PARTNERS LLP 228,500 233,300 2.10 455 513 12.75
2018-05-14 13F-HR BOOTHBAY FUND MANAGEMENT, LLC 12,110 0 -100.00 24 0 -100.00
2018-05-14 13F-HR TEACHERS ADVISORS INC 257,124 257,124 0.00 512 566 10.55
2018-04-26 13F-HR SIMPLEX TRADING, LLC Put 10 104 940.00 0 5
2018-05-14 13F-HR ALLIANCEBERNSTEIN L.P. 49,600 62,300 25.60 99 137 38.38
2018-05-15 13F-HR AQR CAPITAL MANAGEMENT LLC 171,839 113,106 -34.18 342 249 -27.19
2018-05-18 13F-HR/A ROYAL BANK OF CANADA 16,572 13,796 -16.75 33 30 -9.09
2018-04-27 13F-HR Chicago Partners Investment Group LLC 100 0
2018-05-04 13F-HR PRUDENTIAL FINANCIAL INC 14,270 14,270 0.00 28 31 10.71
2018-07-13 13F-HR BANK OF MONTREAL /CAN/ 0 1,022 0 3
2018-05-16 13F-HR/A GROUP ONE TRADING, L.P. Call 6,900 31,700 359.42 14 70 400.00
2018-05-09 13F-HR IFP Advisors, Inc 95 95 0.00 0 0
2018-05-14 13F-HR/A CITADEL ADVISORS LLC Put 14,000 0 -100.00 28 0 -100.00
2018-05-14 13F-HR Veritable, L.P. 100,000 100,000 0.00 199 220 10.55
2018-05-15 13F-HR PERCEPTIVE ADVISORS LLC 3,745,662 0 -100.00 7,454 0 -100.00
2018-04-23 13F-HR Oak Asset Management, Llc 10,000 10,000 0.00 20 22 10.00
2018-05-11 13F-HR BNP PARIBAS ARBITRAGE, SA 29,746 30,363 2.07 59,195 66,799 12.85
2018-05-14 13F-HR Virtu Financial LLC 58,575 0 -100.00 117 0 -100.00
2018-05-14 13F-HR Brown Advisory Securities, LLC 275,000 275,000 0.00 547 605 10.60
2018-05-15 13F-HR LPL Financial LLC 19,391 28,191 45.38 39 62 58.97
2017-05-16 13F-HR JANUS CAPITAL MANAGEMENT LLC 186,149 0 -100.00 434 0 -100.00
2018-05-01 13F-HR Hanson McClain, Inc. 200 200 0.00 0 0
2018-05-01 13F-HR SFE Investment Counsel 60,000 60,000 0.00 119 132 10.92
2018-05-03 13F-HR ZEKE CAPITAL ADVISORS, LLC 10,811 10,811 0.00 22 24 9.09
2018-05-15 13F-HR ARMISTICE CAPITAL, LLC 7,600,000 12,560,000 65.26 15,124 27,632 82.70
2018-05-15 13F-HR Parallax Volatility Advisers, L.P. 22,218 0 -100.00 44 0 -100.00
2018-05-15 13F-HR PANAGORA ASSET MANAGEMENT INC 906,017 1,295,291 42.97 1,803 2,850 58.07
2018-05-15 13F-HR STATE STREET CORP 2,449,128 2,524,844 3.09 4,873 5,555 14.00
2018-05-11 13F-HR MML INVESTORS SERVICES, LLC 30,900 28,100 -9.06 61 62 1.64
2018-05-15 13F-HR GOLDMAN SACHS GROUP INC 129,470 123,511 -4.60 257 271 5.45
2018-05-03 13F-HR SG Americas Securities, LLC 40,450 12,052 -70.21 80 27 -66.25
2018-05-02 13F-HR RHUMBLINE ADVISERS 124,616 122,816 -1.44 248 270 8.87
2018-05-15 13F-HR Ameritas Investment Partners, Inc. 12,612 12,612 0.00 25 28 12.00
2018-05-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP Put 22,500 28,600 27.11 45 63 40.00
2018-07-20 13F-HR Creative Planning 13,500 13,753 1.87 30 35 16.67
2018-05-15 13F-HR Tower Research Capital LLC (TRC) 4,416 832 -81.16 9 2 -77.78
2017-08-08 13F-HR Airain ltd 27,402 0 -100.00 78 0 -100.00
2018-05-17 13F-HR Atlantic Trust Group, LLC 125,000 125,000 0.00 249 275 10.44
2018-05-15 13F-HR VANGUARD GROUP INC 6,067,039 6,237,902 2.82 12,073 13,723 13.67
2018-04-23 13F-HR PERKINS CAPITAL MANAGEMENT INC 252,000 303,000 20.24 501 667 33.13
2018-07-18 13F-HR AMALGAMATED BANK 19,020 22,299 17.24 42 58 38.10
2018-05-09 13F-HR BlackRock Inc. 9,340,209 9,140,644 -2.14 18,587 20,109 8.19
2018-05-15 13F-HR WOLVERINE TRADING, LLC 0 11,763 0 26
2018-05-14 13F-HR Renaissance Technologies LLC 599,769 0 -100.00 1,194 0 -100.00
2018-05-17 13F-HR Legal & General Group Plc 37,389 25,894 -30.74 75 57 -24.00
2018-05-08 13F-HR Advisornet Financial, Inc 12,220 12,220 0.00 24 27 12.50
2018-04-26 13F-HR SIMPLEX TRADING, LLC Call 2 33 1,550.00 0 0
2018-05-14 13F-HR GREAT POINT PARTNERS LLC 0 500,000 0 1,100,000
2017-11-09 13F-HR TFS CAPITAL LLC 16,613 0 -100.00 53 0 -100.00
2018-05-11 13F-HR CITIGROUP INC 39,447 42,543 7.85 78 94 20.51
2018-05-15 13F-HR ELEMENT CAPITAL MANAGEMENT LLC 0 14,453 0 32
2018-05-14 13F-HR ProShare Advisors LLC 21,332 18,367 -13.90 42 40 -4.76
2018-05-14 13F-HR Stone Ridge Asset Management LLC 19,240 17,740 -7.80 38 39 2.63
2018-05-09 13F-HR NORTHERN TRUST CORP 1,616,011 1,599,160 -1.04 3,216 3,518 9.39
2017-07-24 13F-HR Carl Domino Inc 32,500 32,500 0.00 92 105 14.13
2018-05-14 13F-HR PARAMETRIC PORTFOLIO ASSOCIATES LLC 13,202 16,659 26.19 26 37 42.31
2018-05-04 13F-HR STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM 59,413 59,413 0.00 118 131 11.02
2018-05-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP Call 16,100 19,900 23.60 32 44 37.50
2018-04-16 13F-HR Raymond James Financial Services Advisors, Inc. 180,666 148,046 -18.06 360 326 -9.44
2018-05-15 13F-HR Metlife Investment Advisors, Llc 18,820 71,731 281.14 37 158 327.03
2018-05-15 13F-HR Cubist Systematic Strategies, LLC 53,713 13,513 -74.84 107 30 -71.96
2018-05-15 13F-HR JANE STREET GROUP, LLC 26,569 0 -100.00 53 0 -100.00
2018-05-08 13F-HR US BANCORP \DE\ 10,000 10,000 0.00 20 22 10.00
2018-05-15 13F-HR Moore Capital Management, LP 140,000 0 -100.00 279 0 -100.00
2017-02-10 13F-HR BlackRock Institutional Trust Company, N.A. 2,820,119 2,820,119 0.00 4,738 6,571 38.69
2018-06-14 13F-HR/A Lara, May & Associates, Llc 20,000 0 -100.00 40 0 -100.00
2018-07-19 13F-HR MYCIO WEALTH PARTNERS, LLC 2,433,500 6,278
2018-05-04 13F-HR First Eagle Investment Management, LLC 50,000 0 -100.00 100 0 -100.00
2018-05-15 13F-HR A.R.T. Advisors, LLC 189,627 97,803 -48.42 377 215 -42.97
2018-05-07 13F-HR SCHWAB CHARLES INVESTMENT MANAGEMENT INC 606,829 711,562 17.26 1,208 1,566 29.64
2018-05-15 13F-HR BARCLAYS PLC 46,751 49,975 6.90 93 109 17.20
2018-05-16 13F-HR/A GROUP ONE TRADING, L.P. Put 19,400 19,800 2.06 39 44 12.82
2018-05-14 13F-HR Baird Financial Group, Inc. 171,310 171,310 0.00 341 377 10.56
2018-05-07 13F-HR AMERICAN INTERNATIONAL GROUP INC 96,793 91,853 -5.10 193 202 4.66
2018-05-02 13F-HR Capital Advantage, Inc. 34,000 34,000 0.00 68 75 10.29
2018-05-14 13F-HR Broadfin Capital, LLC 4,535,647 4,673,247 3.03 9,026 10,281 13.90
2018-05-15 13F-HR Bank of New York Mellon Corp 545,786 563,131 3.18 1,086 1,239 14.09
2018-04-18 13F-HR Sonora Investment Management, LLC 3,000 3,000 0.00 5,970 6,600 10.55
2018-05-09 13F-HR Lee Financial CORP 50 0
2018-02-16 13F-HR/A Commonwealth Equity Services, Inc 49,323 53,673 8.82 159 174 9.43
2018-04-10 13F-HR Chevy Chase Trust Holdings, Inc. 15,000 15,000 0.00 30 33 10.00
2018-05-04 13F-HR M&T BANK CORP 130,000 130,000 0.00 259 286 10.42
2018-05-15 13F-HR Krilogy Financial LLC 2,500 2,500 0.00 5 6 20.00
2018-04-26 13F-HR FALCON POINT CAPITAL, LLC 222,501 490
2018-05-15 13F-HR UBS Group AG 14,986 2,000 -86.65 30 4 -86.67
2018-05-14 13F-HR Commonwealth Equity Services, Llc. 59,373 61,373 3.37 118 135 14.41
2018-04-17 13F-HR Calton & Associates, Inc. 3,500 0 -100.00 7 0 -100.00
2018-05-15 13F-HR Voya Investment Management LLC 65,073 65,073 0.00 129 143 10.85
2018-05-14 13F-HR FMR LLC / Fidelity 2,580,900 2,622,500 1.61 5,136 5,769 12.32
2018-04-24 13F-HR NewSquare Capital LLC 7,258 7,258 0.00 14 16 14.29
2018-07-12 13F-HR James Hambro & Partners 10,000 26
2018-05-15 13F-HR BANK OF AMERICA CORP /DE/ 29,614 54,557 84.23 58 120 106.90
2018-05-15 13F-HR BALYASNY ASSET MANAGEMENT LLC 43,950 0 -100.00 87 0 -100.00
2018-05-15 13F-HR GUGGENHEIM CAPITAL LLC 631,049 530,246 -15.97 1,255 1,166 -7.09
2018-05-11 13F-HR JW Asset Management, LLC 1,878,323 1,770,524 -5.74 3,738 3,895 4.20
2017-02-10 13F-HR BlackRock Fund Advisors 30,001 38,641 28.80 50 90 80.00
2017-02-10 13F-HR BlackRock Advisors LLC 26,095 26,095 0.00 44 61 38.64
2018-04-26 13F-HR SIMPLEX TRADING, LLC 10,130 7,614 -24.84 20 16 -20.00
2018-04-16 13F-HR SII INVESTMENTS INC/WI 15,800 0 -100.00 32 0 -100.00
2018-07-19 13F-HR Ballentine Partners, LLC 100,000 100,000 0.00 220 258 17.27
2017-10-26 13F-HR Acrospire Investment Management LLC 5,250 0 -100.00 17 0 -100.00
2018-05-15 13F-HR BlueCrest Capital Management Ltd 0 14,019 0 31
2018-05-14 13F-HR AVENIR CORP 291,597 291,597 0.00 580 642 10.69
2018-05-15 13F-HR TWO SIGMA ADVISERS, LP 60,319 21,332 -64.63 120 47 -60.83
2018-05-15 13F-HR CREDIT SUISSE AG/ 41,433 50,417 21.68 82 111 35.37
2018-05-10 13F-HR CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 805,200 805,200 0.00 1,602 1,771 10.55
2018-05-14 13F-HR UNITED SERVICES AUTOMOBILE ASSOCIATION 26,095 57
2018-05-14 13F-HR FULLER & THALER ASSET MANAGEMENT, INC. 554,000 517,300 -6.62 1,102 1,138 3.27
2018-05-15 13F-HR DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main 216,709 477
2018-05-15 13F-HR LADENBURG THALMANN FINANCIAL SERVICES INC 8,260 8,860 7.26 16 19 18.75
2018-05-16 13F-HR/A GROUP ONE TRADING, L.P. 15,257 10,684 -29.97 30 24 -20.00
2018-07-20 13F-HR Tiaa, Fsb 491,000 0 -100.00 1,080 0 -100.00
2018-05-15 13F-HR MILLENNIUM MANAGEMENT LLC 10,696 0 -100.00 21 0 -100.00
ATRS : Antares Pharma Stock Analysis and Research Report

2017-10-31 - Asif

Antares Pharma, Inc. is an emerging, specialty pharmaceutical company that focuses on the development and commercialization of self-administered parenteral pharmaceutical products and technologies. Its strategy is to identify new or existing approved drug formulations and apply its drug delivery technology to enhance the drug compounds and delivery methods. The company develop, manufacture and commercialize, for itself or with partners, novel therapeutic products using its advanced drug delivery systems that are designed to help improve safety and efficacy, reduce side effects, and enhance patient comfort and adherence. Its subcutaneous injection technology platforms include the VIBEX® pressure-assisted auto injector system suitable for branded and generic injectable drugs in unit dose containers, reusable needle-free spring-action injector devices, and disposable multi-dose pen injectors for use with standard cartridges. Antares Pharma has a portfolio of proprietary and partnered pro...

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Related News Stories

Swinging For The Fence On Antares Pharma

2018-07-08 seekingalpha
A study from 2009 by Alok Kumar found retail investors exhibit “a greater propensity to gamble” as compared to institutional investors. (62-1)

Core Biotech Buys #18: Thoughts On ASCO And The End Of Core Biotech

2018-06-07 seekingalpha
Novocure strengthened its Board of Directors and Abeona Therapeutics received a key analyst thumbs up. Two possible trades are suggested. (627-6)

Core Biotech Buys #17: Positive Commentary For Gene Therapy And Our First Swap

2018-05-31 seekingalpha
FDA Commissioner Scott Gottlieb´s remarks concerning the potential of gene therapy, bode well for stocks participating in that theme. (666-4)

Redux: My 3 January Effect Candidates Are Producing Major Alpha Through May

2018-05-30 seekingalpha
Back in early January my article "3 Biotechs For The January Effect" was published. The article highlighted Geron (GERN), Antares Pharma (ATRS) and AcelRX (ACRX). This article is to assess my picks so far in May and outline prospects going forward to determine if we should sell, hold or buy more. Thus far, all three well overperformed both the Nasdaq (QQQ) as well as their small biotech (SBIO) peer group. (75-1)

Antares Pharma, Excellent Risk-Reward Profile

2018-05-22 seekingalpha
Company remains a viable acquisition candidate, especially in the likely aftermath of Xyosted being approved by the FDA. (68-0)

CUSIP: 036642106